Aby J. Mathew Biolife Solutions Inc (BLFS) insider trading activity

BLFS Quotes by TradingView

Aby J. Mathew is EVP & Chief Scientific Officer of BIOLIFE SOLUTIONS INC. Currently has a direct ownership of 320,165 shares of BLFS, which is worth approximately $8.31 Million. The most recent transaction as insider was on Feb 09, 2023, when has been sold 78 shares (Common Stock) at a price of $24.6 per share, resulting in proceeds of $1,918. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 320K
21.68% 3M change
0.15% 12M change
Total Value Held $8.31 Million

Aby J. Mathew Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 09 2023
SELL
Open market or private sale
$1,918 $24.6 p/Share
78 Reduced 0.03%
273,687 Common Stock
Feb 02 2023
SELL
Open market or private sale
$244,300 $24.43 p/Share
10,000 Reduced 3.52%
273,765 Common Stock
Feb 02 2023
BUY
Exercise of conversion of derivative security
$20,600 $2.06 p/Share
10,000 Added 3.42%
282,765 Common Stock
Feb 01 2023
SELL
Open market or private sale
$228,700 $22.87 p/Share
10,000 Reduced 3.52%
273,765 Common Stock
Feb 01 2023
BUY
Exercise of conversion of derivative security
$20,600 $2.06 p/Share
10,000 Added 3.4%
283,765 Common Stock
Jan 04 2023
SELL
Open market or private sale
$181,000 $18.1 p/Share
10,000 Reduced 3.8%
252,826 Common Stock
Jan 04 2023
BUY
Exercise of conversion of derivative security
$20,600 $2.06 p/Share
10,000 Added 3.67%
262,326 Common Stock
Jan 03 2023
SELL
Open market or private sale
$182,600 $18.26 p/Share
10,000 Reduced 3.8%
252,826 Common Stock
Jan 03 2023
BUY
Grant, award, or other acquisition
-
20,939 Added 7.11%
273,765 Common Stock
Jan 03 2023
BUY
Exercise of conversion of derivative security
$20,600 $2.06 p/Share
10,000 Added 3.8%
253,326 Common Stock
Dec 28 2022
SELL
Open market or private sale
$12,032 $16.9 p/Share
712 Reduced 0.28%
252,826 Common Stock
Nov 29 2022
SELL
Open market or private sale
$8,689 $19.93 p/Share
436 Reduced 0.17%
253,538 Common Stock
Nov 10 2022
SELL
Open market or private sale
$2,478 $23.16 p/Share
107 Reduced 0.04%
253,974 Common Stock
Sep 29 2022
SELL
Open market or private sale
$15,124 $23.02 p/Share
657 Reduced 0.26%
254,081 Common Stock
Aug 31 2022
SELL
Open market or private sale
$9,962 $23.44 p/Share
425 Reduced 0.17%
254,738 Common Stock
Aug 14 2022
BUY
Grant, award, or other acquisition
-
411 Added 0.16%
255,163 Common Stock
Aug 10 2022
SELL
Open market or private sale
$2,595 $23.17 p/Share
112 Reduced 0.04%
254,752 Common Stock
Jul 29 2022
BUY
Grant, award, or other acquisition
-
524 Added 0.21%
254,864 Common Stock
Jul 17 2022
BUY
Grant, award, or other acquisition
-
635 Added 0.25%
254,340 Common Stock
Jul 03 2022
BUY
Grant, award, or other acquisition
-
690 Added 0.27%
253,705 Common Stock
Jun 28 2022
SELL
Open market or private sale
$10,461 $14.86 p/Share
704 Reduced 0.28%
253,015 Common Stock
Jun 19 2022
BUY
Grant, award, or other acquisition
-
733 Added 0.29%
253,719 Common Stock
Jun 05 2022
BUY
Grant, award, or other acquisition
-
735 Added 0.29%
252,986 Common Stock
May 27 2022
SELL
Open market or private sale
$5,100 $14.53 p/Share
351 Reduced 0.14%
252,251 Common Stock
May 22 2022
BUY
Grant, award, or other acquisition
-
786 Added 0.31%
252,602 Common Stock
AJM

Aby J. Mathew

EVP & Chief Scientific Officer
Bothell, WA

Track Institutional and Insider Activities on BLFS

Follow BIOLIFE SOLUTIONS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLFS shares.

Notify only if

Insider Trading

Get notified when an Biolife Solutions Inc insider buys or sells BLFS shares.

Notify only if

News

Receive news related to BIOLIFE SOLUTIONS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BLFS